Stryker and Siemens Healthineers Partner to Develop Robotic Neurovascular System for Stroke and Aneurysm Treatment
Key Insights
Stryker and Siemens Healthineers (search) announced a strategic partnership to develop a first-of-its-kind robotic system for comprehensive neurovascular procedures, including stroke (search) and aneurysm (search) treatments.
The collaboration combines Siemens Healthineers (search)' robotics and imaging expertise with Stryker's neurovascular technologies to create an integrated ecosystem aimed at improving procedural precision and physician performance.
The partnership addresses a significant global health burden, as stroke (search) is the second-leading cause of death and third-leading cause of disability in adults worldwide.
Stryker and Siemens Healthineers (search) announced a strategic partnership to develop a first-of-its-kind robotic system capable of performing a comprehensive range of elective and emergency neurovascular procedures, including treatment for strokes and aneurysms. The collaboration brings together Siemens Healthineers' expertise in robotics and image-guided therapy with Stryker's neurovascular technologies experience.
Addressing Critical Global Health Burden
The partnership targets a significant medical challenge, as stroke (search) represents the second-leading cause of death and the third-leading cause of disability in adults globally, according to Siemens Healthineers (search). Currently, many neurovascular procedures require physicians to simultaneously manage multiple systems and tools, which can add complexity and reduce efficiency during critical interventions.
"Neurovascular diseases (search) – primarily strokes and aneurysms – carry a massive global burden," said Carsten Bertram, head of Advanced Therapies at Siemens Healthineers (search). "We are excited to announce this partnership, especially with Stryker, a leading player in the field of neurovascular care. Together, we are uniquely positioned to create an ecosystem of image-guidance, robotics and devices."
Comprehensive Development Approach
The collaboration encompasses multiple facets of development, including robotic system design, access device and implant integration, imaging for robotic navigation, and procedural workflow optimization. By bringing robotics, imaging, and therapeutic devices together in a single ecosystem, the companies aim to enhance physician performance, improve procedural precision, and enable faster treatment.
The integrated approach is designed to help improve patient outcomes in both complex hemorrhagic cases (search) and time-sensitive ischemic strokes (search), where rapid intervention is critical for patient survival and recovery.
Clinical Validation and Implementation
The initial phase of the partnership will focus on co-developing the integrated ecosystem and validating its clinical value in collaboration with leading physicians. This approach ensures that the robotic system will meet real-world clinical needs and workflow requirements.
"By combining our deep expertise in stroke (search) therapy devices with the leadership of Siemens Healthineers (search) in robotics and imaging, we aim to simplify workflows, enhance precision, and accelerate care," said Jim Marucci, president of Stryker's Neurovascular division. "Together, we are taking an important step toward transforming how neurovascular procedures are performed – and ultimately, working to improve outcomes for patients worldwide."
Industry Context
The partnership represents part of a broader trend in medical device development, with companies increasingly collaborating to create specialized surgical robots. The neurovascular robotics field represents a particularly challenging area due to the precision required for procedures involving delicate brain vasculature and the time-sensitive nature of stroke (search) interventions.